Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches: Preclinical R&D Development

March 7, 2013
Perlmutter to lead global R&D efforts  Read More »

March 7, 2013
Gains Cynviloq and drug formulation technology  Read More »

March 6, 2013
Enters CDMO space with acquisition  Read More »

March 6, 2013
Will double filling, formulation and development capacity  Read More »

March 6, 2013
R&D pact cover cell culture systems for stem cells  Read More »

March 6, 2013
Aims to advance Quarfloxin and associated anticancer technologies  Read More »

March 6, 2013
Revises product line-up and termination date   Read More »

March 5, 2013
DSM will produce eribulin mesylate for the U.S. market  Read More »

March 5, 2013
Adds Dry Powder Manufacturing Capabilities  Read More »

March 5, 2013
Aims to strengthen antibody development and commercial opportunities  Read More »

March 5, 2013
Adds capabilities for solid dispersions and oral solid dosages  Read More »

March 5, 2013
Will provide scale-up, process validation, and commercial scale supply  Read More »

March 5, 2013
Obtains license to TRM assay and associated trademark  Read More »

March 4, 2013
Expands geographic footprint  Read More »

March 4, 2013
Expands ops in Russia and Eastern Europe  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On